001     294751
005     20250520092806.0
024 7 _ |a 10.1007/s00330-024-11191-8
|2 doi
024 7 _ |a pmid:39604650
|2 pmid
024 7 _ |a 0938-7994
|2 ISSN
024 7 _ |a 1432-1084
|2 ISSN
024 7 _ |a 1613-3749
|2 ISSN
024 7 _ |a 1613-3757
|2 ISSN
024 7 _ |a (ISSN
|2 ISSN
024 7 _ |a DES
|2 ISSN
024 7 _ |a SUPPLEMENTS)
|2 ISSN
037 _ _ |a DKFZ-2024-02466
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Neelsen, Christian Jan Oliver
|0 P:(DE-He78)2af28acfaad8f466abb166306f9597bd
|b 0
|e First author
|u dkfz
245 _ _ |a Splenic T2 signal intensity loss on MRI is associated with disease burden in multiple myeloma.
260 _ _ |a Heidelberg
|c 2025
|b Springer
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1747726040_3491
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:E010# / 2025 Jun;35(6):3576-3586
520 _ _ |a This study aims to evaluate correlations between spleen signal changes in different MRI sequences and bone marrow plasma cell infiltration as potential indicator of disease burden in multiple myeloma (MM) patients.We retrospectively analyzed 45 patients with newly diagnosed MM that underwent whole-body MRI with axial DWI at b-values 50 (b50) and 800 (b800), and coronal T1 and T2 fast spin-echo (T2-TSE) imaging. A subcohort of 39 patients had concomitant [18F]FDG PET/CT. The spleen was segmented in all MRI sequences and signal intensities were normalized. MR signal intensities and ADC values were correlated with bone marrow plasma cell infiltration from biopsy, laboratory markers (Beta 2-microglobulin, M-Protein, Red blood count (RBC), Hemoglobin, Hematocrit, Total protein, Creatinine), clinical data (ISS stages, high-risk chromosomal aberrations), and standardized uptake value (SUV) in the spleen as well as spleen-to-liver and spleen-to-blood pool SUV ratios on [18F]FDG PET-CT.Bone marrow plasma cell infiltration was negatively correlated with (normalized) mean splenic signal intensity on DWI-b50, DWI-b800, and T2-TSE images (r = -0.64, p < 0.001, r = -0.58, p < 0.001, and r = -0.66, p < 0.001, respectively) while there was no correlation with the apparent diffusion coefficient or spleen size (p = 0.52). In the subgroup analysis of 39 patients with concomitant [18F]FDG PET-CT, there was no correlation of normalized splenic [18F]FDG uptake either with MR spleen signal (for T2 p = 0.64) or with bone marrow plasma cell infiltration (p = 0.37).Our findings reveal a significant association between spleen signal intensity especially on normalized T2-weighted images and tumor burden.Question What changes occur in spleen signal on MRI as tumor load marker changes in multiple myeloma (MM)? Findings Spleen signal intensity, particularly on T2-weighted MRI, negatively correlates with bone marrow plasma cell infiltration and laboratory markers of tumor burden. Clinical relevance Standardized quantification of splenic T2 signal is proposed as a new marker for MM disease burden.
536 _ _ |a 315 - Bildgebung und Radioonkologie (POF4-315)
|0 G:(DE-HGF)POF4-315
|c POF4-315
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Multiparametric magnetic resonance imaging
|2 Other
650 _ 7 |a Multiple myeloma
|2 Other
650 _ 7 |a Neoplasm staging
|2 Other
650 _ 7 |a Positron emission tomography computed tomography
|2 Other
650 _ 7 |a Spleen
|2 Other
700 1 _ |a Sachpekidis, Christos
|0 P:(DE-He78)69d2d5247c019c2a2075502dc11bf0b2
|b 1
|u dkfz
700 1 _ |a John, Lukas
|b 2
700 1 _ |a Neher, Peter
|0 P:(DE-He78)64313331bb3bdc0902ff88697f402c92
|b 3
|u dkfz
700 1 _ |a Mai, Elias
|b 4
700 1 _ |a Grözinger, Martin
|0 P:(DE-He78)cf4656ab05919cc784af4e9812f5a9fa
|b 5
|u dkfz
700 1 _ |a Paech, Daniel
|0 P:(DE-He78)c6e31fb8f19e185e254174554a0cccfc
|b 6
|u dkfz
700 1 _ |a Dimitrakopoulou-Strauss, Antonia
|0 P:(DE-He78)b2df3652dfa3e19d5e96dfc53f44a992
|b 7
|u dkfz
700 1 _ |a Kurz, Felix T
|0 P:(DE-He78)ea7f20e71e3cb1a864c23f2f09f0b0b9
|b 8
|u dkfz
700 1 _ |a Sauer, Sandra
|b 9
700 1 _ |a Raab, Marc S
|b 10
700 1 _ |a Schlemmer, Heinz-Peter
|0 P:(DE-He78)3d04c8fee58c9ab71f62ff80d06b6fec
|b 11
|u dkfz
700 1 _ |a Wennmann, Markus
|0 P:(DE-He78)e7c860fe438c12cbe5f071b3f86d5738
|b 12
|u dkfz
700 1 _ |a Weinhold, Niels
|b 13
773 _ _ |a 10.1007/s00330-024-11191-8
|0 PERI:(DE-600)1472718-3
|n 6
|p 3576-3586
|t European radiology
|v 35
|y 2025
|x 0938-7994
909 C O |p VDB
|o oai:inrepo02.dkfz.de:294751
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)2af28acfaad8f466abb166306f9597bd
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)69d2d5247c019c2a2075502dc11bf0b2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)64313331bb3bdc0902ff88697f402c92
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)cf4656ab05919cc784af4e9812f5a9fa
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)c6e31fb8f19e185e254174554a0cccfc
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)b2df3652dfa3e19d5e96dfc53f44a992
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)ea7f20e71e3cb1a864c23f2f09f0b0b9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)3d04c8fee58c9ab71f62ff80d06b6fec
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)e7c860fe438c12cbe5f071b3f86d5738
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-315
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Bildgebung und Radioonkologie
|x 0
914 1 _ |y 2024
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2023-08-19
|w ger
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2023-08-19
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-19
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-08-19
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EUR RADIOL : 2022
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-08-19
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-08-19
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b EUR RADIOL : 2022
|d 2023-08-19
920 1 _ |0 I:(DE-He78)E010-20160331
|k E010
|l E010 Radiologie
|x 0
920 1 _ |0 I:(DE-He78)E060-20160331
|k E060
|l E060 KKE Nuklearmedizin
|x 1
920 1 _ |0 I:(DE-He78)E230-20160331
|k E230
|l E230 Medizinische Bildverarbeitung
|x 2
920 0 _ |0 I:(DE-He78)E010-20160331
|k E010
|l E010 Radiologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)E010-20160331
980 _ _ |a I:(DE-He78)E060-20160331
980 _ _ |a I:(DE-He78)E230-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21